Quick Answer
Immunocore Holdings plc reported Shares Outstanding of 50.69 million shares for fiscal year 2025.
Immunocore Holdings plc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 50.69M | +1.2% |
| 2024 | 50.06M | +0.7% |
| 2023 | 49.73M | +3.4% |
| 2022 | 48.09M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 50.47M | +0.9% | +0.2% |
| June 30, 2025 | 50.37M | +0.7% | +0.4% |
| March 31, 2025 | 50.18M | +0.4% | +0.2% |
| December 31, 2024 | 50.06M | +0.7% | +0.1% |
| September 30, 2024 | 50.03M | — | +0.0% |
| June 30, 2024 | 50.02M | — | +0.0% |
| March 31, 2024 | 50.01M | — | +0.6% |
| December 31, 2023 | 49.73M | — | — |
- Immunocore Holdings plc showed an increase of +1.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Immunocore Holdings plc’s shares outstanding has grown by 5.4% (from 48.09 million shares to 50.69 million shares).
- The most recent figure is from Immunocore Holdings plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: